Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S P Langdon

Showing results (41-50 of 77) with videos related to

Pageof 8
Sort By:
European Journal of Cancer (Oxford, England : 1990)|June 15, 2005
The mechanism of action of Kahalalide F: variable cell permeability in human hepatoma cell linesJ M Sewell, I Mayer, S P Langdon, et al.
Peptides|January 1, 1997
Processing of [D-Arg1,D-Phe5,D-Trp7,9,Leu11]substance P in xenograft bearing Nu/Nu miceD A Jones, A J MacLellan, J Cummings, et al.
Biochemical Pharmacology|October 15, 1983
The formation and metabolism of N-hydroxymethyl compounds--IV. Cytotoxicity and antitumour activity of N-hydroxymethylformamide, a putative metabolite of N-methylformamide (NSC 3051)P G Cooksey, E N Gate, A Gescher, et al.
Cancer Research|March 31, 2001
Expression of erbB-4/HER-4 growth factor receptor isoforms in ovarian cancerL M Gilmour, K G Macleod, A McCaig, et al.
British Journal of Cancer|September 1, 1992
12-O-tetradecanoylphorbol 13-acetate induced differentiation in human lung squamous carcinoma cellsG J Rabiasz, S P Langdon, L Anderson, et al.
British Journal of Cancer|May 1, 1992
Transforming growth factor-beta mRNA expression and growth control of human ovarian carcinoma cellsJ M Bartlett, G J Rabiasz, W N Scott, et al.
Peptides|January 1, 1995
Metabolism of the anticancer peptide H-Arg-D-Trp-NmePhe-D-Trp-Leu-Met-NH2D A Jones, J Cummings, S P Langdon, et al.
British Journal of Cancer|March 1, 1996
Metabolism of the broad-spectrum neuropeptide growth factor antagonist: [D-Arg1, D-Phe5, D-Trp7,9, Leu11]-substance PD A Jones, J Cummings, S P Langdon, et al.
British Journal of Cancer|December 18, 2001
Association of c-Raf expression with survival and its targeting with antisense oligonucleotides in ovarian cancerF McPhillips, P Mullen, B P Monia, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 1, 1995
Pharmacokinetics, metabolism, tissue and tumour distribution of the neuropeptide growth factor antagonist [Arg6, D-Trp7,9, NmePhe8]- substance P(6-11) in nude mice bearing the H69 small-cell lung cancer xenograftJ Cummings, A J MacLellan, D A Jones, et al.
Pageof 8

Showing results (41-50 of 77) with videos related to

Sort By:
Pageof 8
European Journal of Cancer (Oxford, England : 1990)|June 15, 2005
The mechanism of action of Kahalalide F: variable cell permeability in human hepatoma cell linesJ M Sewell, I Mayer, S P Langdon, et al.
Peptides|January 1, 1997
Processing of [D-Arg1,D-Phe5,D-Trp7,9,Leu11]substance P in xenograft bearing Nu/Nu miceD A Jones, A J MacLellan, J Cummings, et al.
Biochemical Pharmacology|October 15, 1983
The formation and metabolism of N-hydroxymethyl compounds--IV. Cytotoxicity and antitumour activity of N-hydroxymethylformamide, a putative metabolite of N-methylformamide (NSC 3051)P G Cooksey, E N Gate, A Gescher, et al.
Cancer Research|March 31, 2001
Expression of erbB-4/HER-4 growth factor receptor isoforms in ovarian cancerL M Gilmour, K G Macleod, A McCaig, et al.
British Journal of Cancer|September 1, 1992
12-O-tetradecanoylphorbol 13-acetate induced differentiation in human lung squamous carcinoma cellsG J Rabiasz, S P Langdon, L Anderson, et al.
British Journal of Cancer|May 1, 1992
Transforming growth factor-beta mRNA expression and growth control of human ovarian carcinoma cellsJ M Bartlett, G J Rabiasz, W N Scott, et al.
Peptides|January 1, 1995
Metabolism of the anticancer peptide H-Arg-D-Trp-NmePhe-D-Trp-Leu-Met-NH2D A Jones, J Cummings, S P Langdon, et al.
British Journal of Cancer|March 1, 1996
Metabolism of the broad-spectrum neuropeptide growth factor antagonist: [D-Arg1, D-Phe5, D-Trp7,9, Leu11]-substance PD A Jones, J Cummings, S P Langdon, et al.
British Journal of Cancer|December 18, 2001
Association of c-Raf expression with survival and its targeting with antisense oligonucleotides in ovarian cancerF McPhillips, P Mullen, B P Monia, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 1, 1995
Pharmacokinetics, metabolism, tissue and tumour distribution of the neuropeptide growth factor antagonist [Arg6, D-Trp7,9, NmePhe8]- substance P(6-11) in nude mice bearing the H69 small-cell lung cancer xenograftJ Cummings, A J MacLellan, D A Jones, et al.
Pageof 8